Therefore, we can conclude that ITPP is a promising agent for the treatment and prevention of heart failure through increased tissue oxygen delivery and reduction of HIF‐1 expression may be one of its crucial potential mechanisms of action. The gene discussed is TPP1; the disease is heart failure.